ATI RN
Immune System Drugs Questions
Question 1 of 5
The nurse is preparing to administer routine, recommended immunizations to an immunocompromised 1-year-old child. What is the most important information to know before administering a vaccination?
Correct Answer: A
Rationale: The correct answer is A because knowing the type of vaccine to be administered is crucial for an immunocompromised child to assess its safety and efficacy. Different vaccines have varying levels of risk and efficacy for immunocompromised individuals. Choice B is not directly related to the safety or appropriateness of administering the vaccine. Choice C, while important, does not provide immediate information on the specific vaccine being administered. Choice D, although relevant, does not provide information on the specific vaccine's safety for an immunocompromised child.
Question 2 of 5
The health care provider plans to inject an interferon directly into the patient's wart. What interferon will the nurse prepare?
Correct Answer: C
Rationale: Rationale: The correct answer is C, Interferon alfa n3 (Alferon N), because it is specifically approved for the treatment of warts caused by human papillomavirus (HPV). Alferon N has been shown to have antiviral activity against HPV, making it the most suitable choice for injecting directly into the wart. Interferon alfa 2a (A), Interferon alfacon 1 (B), and Interferon beta 1a (D) are not specifically indicated for the treatment of warts caused by HPV, making them incorrect choices for this scenario.
Question 3 of 5
The nurse has an order to administer oprelvekin (Neumega) to a patient for the first time. Before administering the drug, what allergy would the nurse want to specifically question the patient about?
Correct Answer: B
Rationale: The correct answer is B: Escherichia coli-produced products. Oprelvekin is produced using genetically modified E. coli bacteria. The nurse should question the patient about any allergies to E. coli-produced products to prevent an allergic reaction. Choices A, C, and D are incorrect because oprelvekin is not derived from egg products, lactose, or penicillin.
Question 4 of 5
A patient who is receiving an immune suppressant has been admitted to the unit. What would be a priority action by the nurse?
Correct Answer: C
Rationale: The correct answer is C: Protect the patient from exposure to infection. This is the priority action because immune suppressants weaken the immune system, making the patient more susceptible to infections. By protecting the patient from exposure to infection, the nurse can prevent potential complications and promote the patient's safety. Monitoring nutritional status (A) is important but not as critical as preventing infections. Patient teaching (B) and providing support for adverse effects (D) can be addressed after ensuring the patient's safety from infections.
Question 5 of 5
A 70-year-old patient with acute myelocytic leukemia is receiving sargramostim (Leukine). What is a priority nursing action for this patient?
Correct Answer: B
Rationale: The correct answer is B: Increasing fluids. In a patient with acute myelocytic leukemia receiving sargramostim, hydration is crucial to prevent dehydration and maintain renal function due to the potential for increased urine output. Adequate fluids help prevent complications such as renal impairment and electrolyte imbalances. Providing a quiet environment (A) can be beneficial but not the priority. Comfort measures for nausea (C) are important but do not address the immediate need for hydration. Encouraging appropriate dietary intake (D) is important but not as critical as ensuring adequate fluid intake in this scenario.